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ABSTRACT 
Introduction Children admitted to hospitals in resource-
poor settings remain at risk of both inpatient and post-
discharge mortality. While known risk factors such as 
young age and nutritional status can identify children at 
risk, they do not provide clear mechanistic targets for 
intervention. The Childhood Acute Illness and Nutrition 
(CHAIN) cohort study aims to characterise the biomedical 
and social risk factors for mortality in acutely ill children 
in hospitals and after discharge to identify targeted 
interventions to reduce mortality.
Methods and analysis The CHAIN network is currently 
undertaking a multi-site, prospective, observational 
cohort study, enrolling children aged 1 week to 2 years 
at admission to hospitals at nine sites located in four 
African and two South Asian countries. The CHAIN 
Network supports the sites to provide care according 
to national and international guidelines. Enrolment is 
stratified by anthropometric status and children are 
followed throughout hospitalisation and for 6 months after 
discharge. Detailed clinical, demographic, anthropometric, 
laboratory and social exposures are assessed. Scheduled 
visits are conducted at 45, 90 and 180 days after 
discharge. Blood, stool and rectal swabs are collected 
at enrolment, hospital discharge and follow-up. The 
primary outcome is inpatient or post-discharge death. 
Secondary outcomes include readmission to hospital and 
nutritional status after discharge. Cohort analysis will 
identify modifiable risks, children with distinct phenotypes, 
relationships between factors and mechanisms underlying 
poor outcomes that may be targets for intervention. 
A nested case–control study examining infectious, 
immunological, metabolic, nutritional and other biological 
factors will be undertaken.
Ethics and dissemination This study protocol was 
reviewed and approved primarily by the Oxford Tropical 
Research Ethics Committee, and the institutional review 
boards of all partner sites. The study is being externally 
monitored. Results will be published in open access peer-
reviewed scientific journals and presented to academic 
and policy stakeholders.
Trial registration number NCT03208725.
INTRODUCTION
Despite impressive global reductions in child 
mortality, more than five million children 
under age of 5 die each year.1 These deaths 
occur disproportionately in low-income and 
middle-income countries (LMICs).2 Factors 
underlying mortality risk are complex and 
overlapping, including undernutrition, 
acute and chronic co-morbidities, lack of 
access to care, poor social support systems 
and poverty.3 4 For many vulnerable chil-
dren, these factors contribute to an unstable 
health trajectory, with repeated episodes 
of illness interspersed with short periods of 
incomplete recovery (figure 1). In most areas 
of the world, acutely ill children may not 
access healthcare during episodes of illness.5 
Strengths and limitations of this study
 ► The Childhood Acute Illness and Illness (CHAIN) 
 cohort is a multi-country study that  collects com-
prehensive data on clinical, laboratory, social, eco-
nomic and behavioural exposures at multiple sites 
in Africa and Asia.
 ► Heterogeneity across sites (geography, rural/ur-
ban, varying HIV and malaria prevalence)  increases 
generalisability and may help identify context- 
independent and dependent interventions.
 ► Strict harmonisation of procedures, processes and 
tools allows for comparability between sites.
 ► This study is deliberately focused on hospitalised 
children and is not designed to evaluate factors as-
sociated with prehospital care and timing of presen-
tation to hospital.
 ► Bias may be introduced by loss-to-follow-up after 
hospital discharge if this occurs in more vulner-
able children, or if participation in the study alters 
outcomes.
2  The Childhood Acute Illness and Nutrition Network. BMJ Open 2019;9:e028454. doi:10.1136/bmjopen-2018-028454
Open access 
Of those that do, studies have shown that children who 
are hospitalised have a dramatically higher risk of death 
both during hospitalisation and in the months following 
discharge than their community peers, even when guide-
lines for treatment and clinical follow-up are followed.6–9 
Thus, contact with the health system resulting in hospi-
talisation serves as an indicator of vulnerability and a 
time point where children are readily accessible for inter-
vention.10–13 While many interventions may be available 
in hospitals, there are no clear interventions proven to 
reduce post-discharge mortality. Undernutrition, HIV 
infection at a young age and a history of repeated hospi-
talisation have emerged as important risk factors for 
post-discharge death.3 9 14 
Approximately half of all childhood mortality is associ-
ated with one or more forms of undernutrition, typically 
identified using simple anthropometry.2 Mortality rates 
among children with severe acute malnutrition (SAM) 
are markedly elevated compared with the general popu-
lation,15 but with effective treatment in the community 
without infectious complications, case fatality may be as 
low as 1%–2%.16 17 However, when children with SAM 
are acutely ill, inpatient case fatality is often 15%–20% 
in resource-poor countries, with many additional deaths 
occurring after discharge, even among children who 
appear to be recovering anthropometrically.18 Although 
case fatality rates for children with moderate acute malnu-
trition (MAM) or stunting in hospital and after discharge 
have not been widely reported, MAM and stunting are 
more prevalent than SAM and may contribute to a greater 
number of child deaths.2 19
Current guidelines for the clinical management of 
acutely ill children with SAM, MAM or stunting are not 
supported by strong evidence.20–23 In addition, while 
measures of mid-upper arm circumference, weight-
for-length and length-for-age can identify children as 
malnourished, anthropometry does not identify the 
mechanisms that link undernutrition to mortality nor 
its underlying causes. In typical settings outside human-
itarian emergencies, it is unclear to what extent malnu-
trition is driven by factors other than food intake, 
including recurrent or chronic infection, intestinal or 
systemic inflammation, malabsorption, disability, social 
vulnerability, parental ill-health, maternal education and 
agency, lack of financial resources, poor social support 
and limited access to healthcare.24 Identifying markers of 
vulnerability and the underlying mechanisms that drive 
mortality may offer opportunity to target interventions 
to improve outcomes in many low-resource settings. In 
addition, understanding relationships between biological 
and social risk factors may allow optimisation of interven-
tion packages within specific groups to achieve the largest 
mortality reductions.
The Childhood Acute Illness and Nutrition (CHAIN) 
Network is a collaborative group of investigators working 
across nine sites in four African and two South Asian 
countries committed to improving child survival and 
optimising growth and development outcomes in low- 
resource settings. CHAIN is conducting a prospective 
cohort study with the objective of determining the pheno-
types of groups of children at highest risk, defining the 
mechanisms underlying such risk and identifying modifi-
able targets for intervention.
METHODS
Objectives
The CHAIN Network is conducting a prospective cohort 
study of approximately 4500 children aged 1 week to 
2 years presenting to healthcare facilities with acute 
illness deemed severe enough to require admission to 
hospital at nine sites in six LMICs. Children are followed 
throughout hospitalisation, discharge and for 6 months 
post-discharge. The general objective of the study is to 
characterise acutely ill children and their outcomes in 
hospital and after discharge in order to identify modi-
fiable pathways leading to death. Using these data, the 
CHAIN network will prioritise interventions based on 
deliverability and potential impact.
Specific objectives
1. To determine factors associated with (1) mortality in 
hospital; (2) mortality after discharge; (3) readmission 
to hospital and (4) poor nutritional recovery.
2. To determine differences in clinical, social, and patho-
physiological (eg, metabolic, infectious and immune) 
phenotypes between children of different nutritional 
status at admission, discharge and follow-up.
3. To identify modifiable risk factors and potential in-
terventions to reduce mortality among vulnerable 
children.
The goal of the CHAIN Network is to identify interven-
tions that can reduce child mortality beyond the current 
recommendations for standard of care. Hence, prior to 
participant enrolment, all study sites underwent a formal 
assessment of their capacity and adherence to national 
and international guidelines, including a survey of 
human resources, materials, equipments, pharmaceutical 
stock and laboratory capacity. All sites were provided with 
support to ensure that the minimum standard of care 
Figure 1 A model of unstable health trajectory of a child 
characterised by repeated illness and incomplete recovery.
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achieved was in line with the national and international 
care guidelines. All sites participated in an audit and feed-
back cycle of guideline adherence using the individual 
patient data collected by the CHAIN.
Locations
Participating sites include rural and urban hospitals 
in Bangladesh (icddr,b Dhaka Hospital and Matlab 
Hospital), Burkina Faso (Banfora Regional Referral 
Hospital), Kenya (Kilifi County Hospital, Mbagathi 
Sub-County Hospital and Migori County Referral 
Hospital), Malawi (Queen Elizabeth Central Hospital), 
Pakistan (Civil Hospital, Karachi), and Uganda (Mulago 
Hospital).
Patient and public involvement
The investigators who form the CHAIN Network lead-
ership have extensive experience in the design and 
conduct of trials focused on improving growth and 
survival in children in Africa and Asia. The study was 
designed specifically to reflect patient and public 
priorities (child survival, reductions in hospitalisation 
and improved growth). Working closely with Community 
Advisory Boards at each site, as well as with a robust social 
science team of researchers in Kenya and Bangladesh, 
patient priorities, experience and preferences were care-
fully considered in the design and development of the 
protocol and data collection instruments. The research 
questions were also discussed with a number of internal 
CHAIN Network and external experts in child survival at 
a convention organised by the funder. Caregivers were 
included in the Community Advisory Boards to provide 
input and into the conduct of the study. At the conclu-
sion of the study, results will be disseminated to partic-
ipants via seminars and outreach events led by the site 
Principle Investigators and the Community Advisory 
Boards at each site.
Eligibility
Children aged 7 days to 23 months who are admitted to 
hospital with an acute illness are eligible for enrolment. 
Prior to October 2018, the lower age limit of enrolment 
was 60 days and this was subsequently modified to allow 
the inclusion of younger children.
Exclusion criteria include the following:
 ► Unable to tolerate oral feeds in the 48 hours prior to 
the onset of the current acute illness.
 ► Underlying terminal illness that in the opinion of 
the treating physician is likely to lead to death within 
6 months.
 ► Diagnosed with a condition that in the opinion of the 
treating physician is likely to require surgery within 
6 months.
 ► Diagnosed with a chromosomal abnormality (syndro-
mically or genetically diagnosed abnormality).
 ► Primary reason for admission is trauma or surgery.
 ► Requiring immediate resuscitation at admission 
defined by ongoing cardiac or pulmonary arrest or 
judged to be peri-arrest by the attending physician.
 ► Previous enrolment in the study.
 ► Sibling enrolled in the study.
 ► Caregiver plans to move outside of the hospital catch-
ment area within 6 months.
 ► Caregiver is unwilling to attend study visits.
 ► Lack of informed consent.
Screening
Each site has nominated a day on which weekly recruit-
ment begins. The first eligible child in each enrol-
ment group admitted to the hospital is identified and 
approached for consent. This is repeated for every eligible 
child admitted subsequently until weekly targets are met 
for each enrolment stratum (see table 1). Although this 
is a pseudo-random approach, all the procedures aim to 
ensure that the study population adequately represents 
the spectrum of nutritional states observed over the 
recruitment period.
Potential participants are identified by clinical staff 
and brought to the attention of the study team who verify 
the eligibility. If eligible, the study is explained to care-
givers in their primary language and written informed 
consent to participate is sought. Caregivers who are unable 
to write are asked to provide a witnessed thumbprint. If 
consent is obtained, the child is enrolled and a unique 
study number is allocated. If a child is deemed eligible 
but is too sick for consent to be immediately sought, study 
staff obtain verbal assent to collect both research and clin-
ical samples at that time to avoid multiple needle inser-
tions. If a caregiver who gave assent then chooses not to 
provide full written consent, all research data and samples 
are destroyed. Children classified as orphans or those 
living in alternative care homes are eligible for enrolment 
if an appropriate caregiver is present to provide consent 
on the child’s behalf.
Table 1 Enrolment groups by age and nutritional status
Group
Target 
Enrolment Age >6 months Age 1–6 months Age <1 month
A 1800 MUAC <11.5 cm or kwashiorkor MUAC <11 cm or kwashiorkor MUAC <9.5 cm or kwashiorkor
B 1800 MUAC 11.5 to <12.5 cm MUAC 11 to <12 cm MUAC 9.5–10.4 cm
C 900 MUAC ≥12.5 cm MUAC ≥12 cm MUAC ≥10.5 cm
MUAC, mid-upper arm circumference. 
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Enrolment
Enrolment is stratified by nutritional status, aiming at a 
ratio of 2:2:1 (A: B: C) with group targets of 200 group A: 
200 group B: 100 group C per site (table 1).
Mid-upper arm circumference (MUAC) was chosen 
as the optimal measure for participant selection as it is 
strongly associated with mortality, captures stunted chil-
dren, varies less with dehydration than weight-based 
indices and is easily measured in sick children.25 26
Procedures
All sites completed standardised training on variable 
definitions, identification of clinical signs, measurement 
of anthropometry, case report form (CRF) completion 
and data entry prior to starting the study, and training 
was repeated regularly. An independent study monitor 
(WESTAT) was hired to conduct site assessments to 
ensure harmonisation of study procedures across and 
between sites, as well as to ensure compliance with regu-
latory standards. Results from WESTAT’s monitoring 
visits are for internal purposes and will be made avail-
able to the principal investigators at each site, the study 
funder, and the CHAIN Network leadership and coordi-
nation teams.
On satisfaction of the inclusion criteria and the comple-
tion of informed consent forms, a unique study identifier 
(ID) is allocated. Baseline data, including demographic 
and social information, a detailed clinical examination 
and measurement of vital signs, including pulse oximetry, 
are collected using the standardised CRF. Anthropom-
etry is performed (head circumference, MUAC, weight 
and length). At admission, biological samples, including 
blood (up to 5 mL for research purposes), rectal swabs 
and faecal samples are obtained. All children are offered 
provider-initiated counselling and testing for HIV, and 
a malaria rapid diagnostic test is done. Results of inves-
tigations performed for clinical care (complete blood 
count [CBC], biochemistry, glucose or any other labora-
tory investigations collected) are abstracted and recorded 
for study purposes. After treatment is initiated, data on 
the child’s diet, social circumstances and, if the mother is 
present, maternal mental health screening is undertaken. 
Other data on maternal characteristics collected include 
maternal MUAC, height, weight and demographic data. 
Additional maternal variables are listed in the study’s 
enrolment CRF, which is included as an online supple-
mentary file.
During admission, hospitalised children are reviewed 
daily and specific clinical features indicating illness 
progression and treatments are recorded on a structured 
daily CRF that is entered into the CHAIN database. In 
the event of death in hospital, a standard mortality audit 
questionnaire is completed by a designated member of 
the study team.
At discharge, the same clinical assessment as at admis-
sion, including anthropometry, is conducted and blood 
and faecal sampling are repeated.
Follow-up procedures
A home visit is conducted within 3 days of discharge. The 
location of the household is recorded by Global Posi-
tioning System (GPS) and CRFs are used to capture infor-
mation on the number of people living in the homestead, 
access to clean water and improved sanitation, occupa-
tion, household assets, income and food security. Parents 
and legal guardians are also interviewed about their 
home and social situation, including challenges experi-
enced when keeping their child and family healthy.
Children are followed-up again at 45, 90 and 180 days 
after discharge at the study facilities, irrespective of sched-
uled or unscheduled outpatient visits for medical or nutri-
tional care. A standardised questionnaire ascertaining 
vital status, care-seeking and rehospitalisation history and 
recent dietary intake (up to 7 days before contact with the 
hospital) is collected and anthropometry, rectal swabs, 
faecal specimens and blood samples are repeated at each 
follow-up visit. Maternal mental health is screened again 
at day 45.
Children judged to have significant illness at any 
follow-up visit or at the home visit are referred to an 
appropriate hospital, clinic or nutrition programme. The 
study staff share any test result relevant to the patient’s 
care with the clinical management team and families.
Parents and legal guardians are asked to bring their 
child to the study clinic if they are concerned that the 
child is unwell. Financial reimbursement for transport 
and lost earnings at standard local rates is provided at 
the clinic visit. Study participants who are readmitted to 
study hospitals undergo the standard clinical assessment 
delivered at enrolment. Participants who are admitted to 
hospitals other than the study site hospital have medical 
data abstracted onto standardised hospital readmission 
forms. For deaths occurring outside the hospital, a verbal 
autopsy to evaluate the cause of death is completed within 
28 days of study staff becoming aware of a death, using 
select questions from the WHO standard verbal autopsy 
tool.27
Community participants
To establish community norms, 125 children at each site 
living in the same community as hospitalised participants 
are recruited as community participants based on the 
following inclusion criteria: absence of known untreated 
HIV or tuberculosis (TB); no hospital admission in the 
14 days prior to contact with the study team and no previ-
ously participation in the study. The exclusion criteria 
listed for hospitalised children also apply to community 
participants.
At every site, one in four hospital participants has a 
child enrolled from their community. The selection of 
hospitalised participants is either every fourth participant, 
or, in periods when enrolment in hospital was lower, for 
example, during healthcare workers strikes, one commu-
nity participant was retrospectively enrolled for every 
second hospitalised participant. Community participants 
are identified randomly from the hospitalised participants' 
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home; a random number x (1–4) and direction (north, 
south, east, west) are generated using an online tool 
prior to visiting the home. Random number selection was 
done using a web-based application, Random Number 
Generator/Picker.28 Once at the home of the hospitalised 
participant, the research team begin by visiting the xth 
house in the generated direction and attempt to obtain 
consent to enrol a child within the eligible age range 
from that household. If not successful, they continue in 
the same direction to the next xth house. This is repeated 
until a child is enrolled. Children with severe illness 
requiring hospital admission identified during commu-
nity screening are referred for appropriate care.
When an eligible community participant is identified, 
their caregiver is given information about the study 
and invited to the study clinic for assessment. Following 
confirmation of informed consent, a clinical examination 
and anthropometry are completed and documented, and 
blood and stool samples collected as in the hospitalised 
children. Household and demographic questionnaires 
are also administered. Children in this group requiring 
non-urgent medical care receive basic treatment in the 
study clinic and/or are referred to appropriate treat-
ment centres after enrolment procedures are completed. 
These children remain eligible for inclusion as commu-
nity participants. Financial reimbursement for transport 
and lost earnings at standard local rates is provided to 
each caregiver at the clinic visit. No follow-up is done on 
community participants.
Specimen collection
To ensure comparability, standard operating procedures 
are followed at each site. Blood samples are collected 
at enrolment, each day of hospitalisation, in the event 
of clinical deterioration (defined by the onset of a new 
Integrated Management of Childhood Illness danger 
sign), at discharge, at all follow-up points and at any 
hospital readmission. Blood is collected into a BD 
Vacutainer Hemogard K2EDTA (spray dried) and a red 
top with a clot activator (spray dried) at each time point 
and three dried blood spots on Whatman filter paper 
cards are prepared. At each time point, a CBC and clin-
ical biochemistry, including sodium, potassium, calcium, 
magnesium, urea, creatinine, albumin, bilirubin, alanine 
aminotransferase, inorganic phosphate and alkaline phos-
phate are performed. Blood glucose, HIV testing (Alere 
Determine or Uni-Gold HIV) and malaria rapid diagnos-
tics tests (CareStart HRP2/pLDH) are also performed on 
all children at enrolment and at additional time points, if 
clinically indicated. Caregivers may refuse any sample 
collection during the study without being excluded from 
further follow-up. The schedule for blood collection is 
detailed in table 2.
Fresh stool collected directly or from child diapers is 
transferred into standardised stool collection pots by study 
staff, aliquoted and stored at −80˚C. Advanced pathogen 
detection using Taqman Array Card, sequencing, micro-
biome analysis, metabolomics, and markers of enteric 
inflammation and dysfunction will be conducted on a 
subset of stool samples in the CHAIN nested case–control 
study.
Data management and confidentiality
Data recorded on standardised CRFs are de-identified 
and entered in a secured central database and housed 
on servers in Nairobi with secure offsite backup. Prior to 
and after data entry, paper records are kept in a locked 
room with locked filing cabinets at each site, with access 
limited to investigators and study staff directly involved 
in data collection and entry. For de-identification, only 
Table 2 Schedule of blood samples and tests performed at each collection time point
Admission Discharge Day 45 Day 90 Day 180 Readmission
Results used for 
care
Complete blood count X X X X X X
Biochemistry X X
Glucose X X
Blood gas+lactate* X X
Blood culture* X X




Processed or stored 
for research assays 
only
Dried blood spot X X X X X X
Serum+plasma for storage X X X X X X
Whole blood for storage X X X X X X
Functional immunology* X X X X X X
Peripheral Blood Mononuclear 
Cell (PBMC) extraction*
X X X X X X
Rectal swab and whole stool X X X X X X
*Done at a subset of sites with capacity, thus these are sub-studies.
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participant initials are recorded and any potential iden-
tifier such as date of birth and GPS location are stored 
separately. Site principal investigators or their delegates 
conduct regular internal quality assurance on comple-
tion, data transfer and storage of the Case Reporting 
Forms (CRFs). A central data management system gener-
ates automated queries and reviews incoming data weekly. 
Any missing or implausible data are queried and site 
teams are given specific timeframe to resolve the raised 
issues.
Analysis
Data from all Network sites will be combined as a single 
cohort. Outcomes will be classified into one or more 
of the following, the proportion of children with each 
endpoint described with 95% CIs:
 ► Death at any time during the period of observation 
(primary endpoint).
 ► Death in hospital.
 ► Death after discharge.
 ► Readmission to hospital within 180 days.
 ► Nutritional status at 180 days.
 ► Recovery as defined by survival without readmission or 
development of SAM during 180 days after discharge.
Primary cohort analysis—mortality
The hazard of mortality during the study will be calculated 
using multivariable survival models including (1) clin-
ical signs and symptoms; (2) anthropometric markers of 
wasting and stunting; (3) markers of organ function; (4) 
birth history and prior health and (5) maternal, house-
hold and social factors. The stratified design by location 
and nutritional category will be accounted for with multi-
level fixed and random effects. Subgroup analyses will 
be conducted for inpatient and post-discharge mortality, 
including time-to-event survival analyses. Predictive algo-
rithms will be built using methods such as classification 
and regression trees, boosted regression trees and other 
machine learning methods. Mechanistic pathways will be 
interrogated using structured equation modelling, latent 
class analysis and other methods.
Secondary cohort analysis
Secondary endpoints are rehospitalisation and the pres-
ence of SAM or MAM after 6 months. These will be 
examined using generalised linear models accounting 
for the competing risk of mortality. Growth trajectories 
post-discharge will be compared with WHO standard 
growth curves and modelled in relation to risk factors and 
outcomes as panel data. Differences in mortality between 
sites will be examined in relation to case-mix and under-
lying risk factors such as HIV and socioeconomic factors.
Nested case–control study
A nested case–control design will be utilised to investigate 
mechanisms with advanced laboratory testing on stored 
samples for efficiency. Cases will be defined as (1) chil-
dren who died during follow-up and (2) children who 
are readmitted to hospital. Controls will be selected from 
children who survive to 6 months without readmission 
(‘pure controls’), matched by site and nutritional strata 
to reflect the study design.
Primary analyses will estimate the association between 
the exposures of interest and the odds of poor outcomes 
during follow-up. The exposures of interest in these anal-
yses will include plasma and faecal markers of intestinal 
dysfunction, systemic inflammation, systemic and enteric 
pathogens, ‘maturity’ and diversity of the enteric micro-
biome, proteomic and metabolomic markers of energy 
metabolism, and macronutrient and micronutrient status.
If mortality in the study is lower than expected (500 
observed deaths), the primary case definition will be 
expanded to include children who were enrolled but 
were rehospitalised post-discharge. Samples from these 
children may also be used in a sensitivity analysis to deter-
mine if associations with readmission with severe illness 
(‘near-miss’) differ from those for mortality.
Sample size
Sample size calculations are based on expected events 
(deaths) in the cohort. We anticipate based on prior 
information from the sites that recruiting approximately 
4500 children in the specified strata will result in 500 
deaths in this population. The sample size estimation is 
based on detecting differences in the proportion who die 
post-discharge between moderately malnourished and 
non-malnourished groups. Among non-malnourished 
children, we assumed an inpatient case fatality propor-
tion of 5.0%, a cumulative post-discharge mortality of 
2.5% compared with 7.5% inpatient case fatality among 
moderately malnourished children and allowing for 10% 
loss to follow-up. For a two-sided hypothesis that Ha: 
p2≠p1, with an α of 0.05, a power of 80% is attained for a 
post-discharge case fatality of 4.8% or above.
For laboratory analyses on stored samples, a nested 
case–control approach will compare cases (children who 
die) and controls (children with good recovery) in a 1:2 
ratio matched by site and nutritional strata. We expect 
approximately 500 deaths will occur, with 1000 controls. 
For a two-sided hypothesis that Ha: p2≠p1 at 80% power 
and a significance level of 0.05, this allows for the deter-
mination of an OR of 1.8 for risk factors with a prevalence 
of 5% among controls, and of 1.4 for risk factors with a 
prevalence of 25%. Further analyses using a combined 
secondary endpoint of death and/or rehospitalisation 
will ensure adequate power to detect risk factors with 
lower prevalence.
At each site, inclusion of 125 community participants 
will permit the calculation of descriptive percentages 
as integer values and estimates of community norms of 
continuous variables.29 Across the whole study, 1025 
community participants will be recruited. For a two-sided 
hypothesis that Ha: p2≠p1, at 80% power and a signifi-
cance level of 0.05 and assuming clustering by site, this 
sample size allows for the determination of a prevalence 
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ratio of 1.5 for risk factors with a prevalence of 5% among 
community participants and a ratio of 1.25 for risk factors 
with a prevalence of 25%.
Study timeline
The CHAIN Cohort Study began enrolling on 20th 
November 2016 and participant recruitment and 
follow-up is expected to occur through August 2019.
Potential challenges and limitations
The study is designed and powered to detect associa-
tions with mortality, the primary outcome. Prior data 
from other studies conducted at the CHAIN sites suggest 
that sufficient numbers of events will occur to achieve 
adequate power. However, an interim analysis will be 
conducted in 2019 to confirm that the cohort study is 
adequately powered to detect the effects of covariates of 
interest. In the event that mortality or enrolment rates 
are not sufficient, we will include rehospitalisations as a 
combined primary endpoint. This cohort study is being 
conducted in low-resource environments where the risk 
of civil, political or military disruption, and industrial 
action affecting hospitals are significant. The inclusion of 
multiple sites across a wide geographical range allows for 
some sites to strategically increase enrolment if other sites 
are unable to achieve planned targets.
Bias may occur if children lost to follow-up are not 
representative of the study population; it is anticipated 
that non-attenders may be more vulnerable. There is also 
the risk of the Hawthorne effect where involvement in the 
study alters outcomes.
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